Table of Contents USA Tuberculosis Drugs Market Report 2012-2023 1 Tuberculosis Drugs Overview 1.1 Product Overview and Scope of Tuberculosis Drugs 1.2 Classification of Tuberculosis Drugs by Product Category 1.2.1 USA Tuberculosis Drugs Sales (K Units) Comparison by Types (2012-2023) 1.2.2 USA Tuberculosis Drugs Sales (K Units) Market Share by Types in 2017 1.2.3 First-line Anti-TB Drugs 1.2.4 Second-line Anti-TB Drugs 1.3 USA Tuberculosis Drugs Market by Application/End Users 1.3.1 USA Tuberculosis Drugs (K Units) and Market Share Comparison by Applications (2012-2023) 1.3.2 New Patients 1.3.3 Drug Resistant TB Patients 1.4 USA Tuberculosis Drugs Market by Region 1.4.1 USA Tuberculosis Drugs Revenue (Million USD) Comparison by Regions (2012-2023) 1.4.2 Northeast Status and Prospect (2012-2023) 1.4.3 Midwest Status and Prospect (2012-2023) 1.4.4 South Status and Prospect (2012-2023) 1.4.5 West Status and Prospect (2012-2023) 1.5 USA Sales and Revenue ofSales and Revenue of Tuberculosis Drugs (2012-2023) 1.5.1 USA Tuberculosis Drugs Sales (K Units) and Growth Rate (2012-2023) 1.5.2 USA Tuberculosis Drugs Revenue (Million USD) and Growth Rate (2012-2023) 2 Industrial Chain Analysis 2.1 Industry Chain Structure of Tuberculosis Drugs 2.2 Raw Material Analysis of Tuberculosis Drugs 2.1.1 Raw Material A Market Analysis 2.1.2 Raw Material B Market Analysis 2.1.3 Raw Material C Market Analysis 2.3 Labor Cost Analysis of Tuberculosis Drugs 2.4 Other Costs Analysis of Tuberculosis Drugs 2.5 Manufacturing Cost Structure Analysis of Tuberculosis Drugs 2.6 Manufacturing Process Analysis of Tuberculosis Drugs 2.7 Raw Materials Sources of Tuberculosis Drugs Major Manufacturers in 2018 2.8 Downstream Buyers 3 USA Tuberculosis Drugs Players/Suppliers Profiles and Sales Data 3.1 Sanofi 3.1.1 Company Basic Information, Manufacturing Base and Competitors 3.1.2 Tuberculosis Drugs Product Category, Application and Specification 3.1.2.1 Product A 3.1.2.2 Product B 3.1.3 Sanofi Tuberculosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.1.4 Sanofi Different Types of Tuberculosis Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.1.5 Sanofi Tuberculosis Drugs Volume in Different Applications and Its Application Share 3.2 Pfizer 3.2.1 Company Basic Information, Manufacturing Base and Competitors 3.2.2 Tuberculosis Drugs Product Category, Application and Specification 3.2.2.1 Product A 3.2.2.2 Product B 3.2.3 Pfizer Tuberculosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.2.4 Pfizer Different Types of Tuberculosis Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.2.5 Pfizer Tuberculosis Drugs Volume in Different Applications and Its Application Share 3.3 Janssen Products 3.3.1 Company Basic Information, Manufacturing Base and Competitors 3.3.2 Tuberculosis Drugs Product Category, Application and Specification 3.3.2.1 Product A 3.3.2.2 Product B 3.3.3 Janssen Products Tuberculosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.3.4 Janssen Products Different Types of Tuberculosis Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.3.5 Janssen Products Tuberculosis Drugs Volume in Different Applications and Its Application Share 3.4 Otsuka 3.4.1 Company Basic Information, Manufacturing Base and Competitors 3.4.2 Tuberculosis Drugs Product Category, Application and Specification 3.4.2.1 Product A 3.4.2.2 Product B 3.4.3 Otsuka Tuberculosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.4.4 Otsuka Different Types of Tuberculosis Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.4.5 Otsuka Tuberculosis Drugs Volume in Different Applications and Its Application Share 3.5 AstraZeneca 3.5.1 Company Basic Information, Manufacturing Base and Competitors 3.5.2 Tuberculosis Drugs Product Category, Application and Specification 3.5.2.1 Product A 3.5.2.2 Product B 3.5.3 AstraZeneca Tuberculosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.5.4 AstraZeneca Different Types of Tuberculosis Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.5.5 AstraZeneca Tuberculosis Drugs Volume in Different Applications and Its Application Share 3.6 Lupin Pharmaceuticals 3.6.1 Company Basic Information, Manufacturing Base and Competitors 3.6.2 Tuberculosis Drugs Product Category, Application and Specification 3.6.2.1 Product A 3.6.2.2 Product B 3.6.3 Lupin Pharmaceuticals Tuberculosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.6.4 Lupin Pharmaceuticals Different Types of Tuberculosis Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.6.5 Lupin Pharmaceuticals Tuberculosis Drugs Volume in Different Applications and Its Application Share 3.7 Akorn 3.7.1 Company Basic Information, Manufacturing Base and Competitors 3.7.2 Tuberculosis Drugs Product Category, Application and Specification 3.7.2.1 Product A 3.7.2.2 Product B 3.7.3 Akorn Tuberculosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.7.4 Akorn Different Types of Tuberculosis Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.7.5 Akorn Tuberculosis Drugs Volume in Different Applications and Its Application Share 3.8 STI Pharma 3.8.1 Company Basic Information, Manufacturing Base and Competitors 3.8.2 Tuberculosis Drugs Product Category, Application and Specification 3.8.2.1 Product A 3.8.2.2 Product B 3.8.3 STI Pharma Tuberculosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.8.4 STI Pharma Different Types of Tuberculosis Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.8.5 STI Pharma Tuberculosis Drugs Volume in Different Applications and Its Application Share 3.9 Sandoz 3.9.1 Company Basic Information, Manufacturing Base and Competitors 3.9.2 Tuberculosis Drugs Product Category, Application and Specification 3.9.2.1 Product A 3.9.2.2 Product B 3.9.3 Sandoz Tuberculosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.9.4 Sandoz Different Types of Tuberculosis Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.9.5 Sandoz Tuberculosis Drugs Volume in Different Applications and Its Application Share 3.10 Labatec Pharma SA 3.10.1 Company Basic Information, Manufacturing Base and Competitors 3.10.2 Tuberculosis Drugs Product Category, Application and Specification 3.10.2.1 Product A 3.10.2.2 Product B 3.10.3 Labatec Pharma SA Tuberculosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.10.4 Labatec Pharma SA Different Types of Tuberculosis Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) and (2012-2017) 3.10.5 Labatec Pharma SA Tuberculosis Drugs Volume in Different Applications and Its Application Share 3.11 Archivel Farma 3.12 BioMerieux 3.13 Cepheid 3.14 Epistem 4 USA Tuberculosis Drugs Competition by Players/Manufacturers, Region, Type and Application 4.1 USA Tuberculosis Drugs Market Competition by Players/Manufacturers 4.1.1 USA Tuberculosis Drugs Sales (K Units) and Market Share of Key Players/Suppliers (2012-2017) 4.1.2 USA Tuberculosis Drugs Revenue (Million USD) and Share by Players/Suppliers (2012-2017) 4.2 USA Tuberculosis Drugs Sales and Revenue by Type 4.2.1 USA Tuberculosis Drugs Sales (K Units) and Market Share by Type (2012-2017) 4.2.2 USA Tuberculosis Drugs Revenue (Million USD) and Market Share by Type (2012-2017) 4.3 USA Tuberculosis Drugs Sales and Revenue by Application 4.3.1 USA Tuberculosis Drugs Sales (K Units) and Market Share by Regions (2012-2017) 4.3.2 USA Tuberculosis Drugs Revenue (Million USD) and Market Share (%) Regions (2012-2017) 4.4 USA Tuberculosis Drugs Sales (K Units) by Application 5 Northeast Tuberculosis Drugs (Sales, Revenue and Price) 5.1 Northeast Tuberculosis Drugs Sales and Value (2012-2017) 5.1.1 Northeast Tuberculosis Drugs Sales (K Units) and Growth Rate (2012-2017) 5.1.2 Northeast Tuberculosis Drugs Revenue and Growth Rate (2012-2017) 5.1.3 Northeast Tuberculosis Drugs Sales Price (USD/Unit) Trend (2012-2017) 5.2 Northeast Tuberculosis Drugs Sales (K Units) and Market Share by Type 5.3 Northeast Tuberculosis Drugs Sales (K Units) and Market Share by Application 6 Midwest Tuberculosis Drugs (Sales, Revenue and Price) 6.1 Midwest Tuberculosis Drugs Sales and Value (2012-2017) 6.1.1 Midwest Tuberculosis Drugs Sales (K Units) and Growth Rate (2012-2017) 6.1.2 Midwest Tuberculosis Drugs Revenue and Growth Rate (2012-2017) 6.1.3 Midwest Tuberculosis Drugs Sales Price (USD/Unit) Trend (2012-2017) 6.2 Midwest Tuberculosis Drugs Sales (K Units) and Market Share by Type 6.3 Midwest Tuberculosis Drugs Sales (K Units) and Market Share by Application 7 South Tuberculosis Drugs (Sales, Revenue and Price) 7.1 South Tuberculosis Drugs Sales and Value (2012-2017) 7.1.1 South Tuberculosis Drugs Sales (K Units) and Growth Rate (2012-2017) 7.1.2 South Tuberculosis Drugs Revenue and Growth Rate (2012-2017) 7.1.3 South Tuberculosis Drugs Sales Price (USD/Unit) Trend (2012-2017) 7.2 South Tuberculosis Drugs Sales (K Units) and Market Share by Type 7.3 South Tuberculosis Drugs Sales (K Units) and Market Share by Application 8 West Tuberculosis Drugs (Sales, Revenue and Price) 8.1 West Tuberculosis Drugs Sales and Value (2012-2017) 8.1.1 West Tuberculosis Drugs Sales (K Units) and Growth Rate (2012-2017) 8.1.2 West Tuberculosis Drugs Revenue and Growth Rate (2012-2017) 8.1.3 West Tuberculosis Drugs Sales Price (USD/Unit) Trend (2012-2017) 8.2 West Tuberculosis Drugs Sales (K Units) and Market Share by Type 8.3 West Tuberculosis Drugs Sales (K Units) and Market Share by Application 11 Marketing Strategy Analysis, Distributors/Traders 11.1 Direct Marketing 11.1.1 Direct Marketing 11.1.2 Indirect Marketing 11.1.3 Marketing Channel Development Trend 11.2 Market Positioning 11.2.1 Pricing Strategy 11.2.2 Brand Strategy 11.2.3 Target Client 11.3 Distributors/Traders List 12 USA Tuberculosis Drugs Market Forecast (2018-2023) 12.1 USA Tuberculosis Drugs Sales (K Units), Revenue and Price Forecast (2018-2023) 12.1.1 USA Tuberculosis Drugs Sales (K Units) and Growth Rate Forecast (2018-2023) 12.1.2 USA Tuberculosis Drugs Revenue and Growth Rate Forecast (2018-2023) 12.1.3 USA Tuberculosis Drugs Price and Trend Forecast (2018-2023) 12.2 USA Tuberculosis Drugs Sales (K Units), Revenue and Growth Rate Forecast by Region (2018-2023) 12.2.1 USA Tuberculosis Drugs Sales (K Units) and Growth Rate Forecast by Region (2018-2023) 12.2.2 USA Tuberculosis Drugs Revenue and Growth Rate Forecast by Region (2018-2023) 12.2.3 Northeast Tuberculosis Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 12.2.4 Midwest Tuberculosis Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 12.2.5 Midwest Tuberculosis Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 12.2.6 West Tuberculosis Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 12.3 USA Tuberculosis Drugs Sales, Revenue and Price Forecast by Type (2018-2023) 12.3.1 USA Tuberculosis Drugs Sales Forecast by Type (2018-2023) 12.3.2 USA Tuberculosis Drugs Revenue Forecast by Type (2018-2023) 12.3.3 USA Tuberculosis Drugs Price Forecast by Type (2018-2023) 12.4 USA Tuberculosis Drugs Sales Forecast by Application (2018-2023) 13 Research Findings and Conclusion 14 Appendix 14.1 Methodology/Research Approach 14.1.1 Research Programs/Design 14.1.2 Market Size Estimation 14.1.3 Market Breakdown and Data Triangulation 14.2 Data Source 14.2.1 Secondary Sources 14.2.2 Primary Sources 14.3 Disclaimer

List of Tables and Figures Figure USA Market Size (Million USD) Comparison 2012-2023 Table USA Market Tuberculosis Drugs Revenue (Million USD) Comparison by Regions 2012-2023 Table USA Tuberculosis Drugs Sales (K Units) and Revenue (Million USD) Market Split by Product Type Table USA Tuberculosis Drugs Sales (K Units) by Application (2016-2023) Figure Product Picture of Tuberculosis Drugs Table USA Tuberculosis Drugs Sales (K Units) and Growth Rate (%) Comparison by Types (2012-2023) Figure USA Tuberculosis Drugs Sales (K Units) Market Share by Types in 2017 Figure First-line Anti-TB Drugs Picture Figure Second-line Anti-TB Drugs Picture Table USA Tuberculosis Drugs Sales (K Units) Comparison by Applications (2012-2023) Figure USA Sales Market Share of Tuberculosis Drugs by Applications in 2017 Figure New Patients Examples Figure Drug Resistant TB Patients Examples Figure Examples Table USA Market Tuberculosis Drugs Revenue (Million USD) Comparison by Regions 2012-2023 Figure Northeast Tuberculosis Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure Midwest Tuberculosis Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure South Tuberculosis Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure West Tuberculosis Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure USA Tuberculosis Drugs Sales (K Units) and Growth Rate (2012-2023) Figure USA Tuberculosis Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure New Project SWOT Analysis of Tuberculosis Drugs Table Industry News List of Tuberculosis Drugs Figure Industry Chain Structure of Tuberculosis Drugs Table Raw Material Suppliers and Price Analysis Figure Global Raw Material A Price Trend (USD/MT) Figure Global Raw Material B Price Trend (USD/MT) Figure Global Raw Material C Price Trend (USD/MT) Table Manufacturing Cost Structure Analysis of Tuberculosis Drugs in 2017 Figure Manufacturing Process Analysis of Tuberculosis Drugs Table Raw Materials Sources of Tuberculosis Drugs Major Manufacturers in 2017 Table Major Buyers of Tuberculosis Drugs Table Sanofi Basic Information List Table Sanofi Tuberculosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Sanofi Tuberculosis Drugs Sales Growth Rate (2012-2017) Figure Sanofi Tuberculosis Drugs Sales USA Market Share (%) (2012-2017) Figure Sanofi Tuberculosis Drugs Revenue USA Market Share (%) (2012-2017) Table First-line Anti-TB Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Second-line Anti-TB Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Sanofi Tuberculosis Drugs Volume in and Its Application Share Table Sanofi Tuberculosis Drugs Volume in and Its Application Share Table Sanofi Tuberculosis Drugs Volume in and Its Application Share Table Pfizer Basic Information List Table Pfizer Tuberculosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Pfizer Tuberculosis Drugs Sales Growth Rate (2012-2017) Figure Pfizer Tuberculosis Drugs Sales USA Market Share (%) (2012-2017) Figure Pfizer Tuberculosis Drugs Revenue USA Market Share (%) (2012-2017) Table First-line Anti-TB Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Second-line Anti-TB Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Pfizer Tuberculosis Drugs Volume in and Its Application Share Table Pfizer Tuberculosis Drugs Volume in and Its Application Share Table Pfizer Tuberculosis Drugs Volume in and Its Application Share Table Janssen Products Basic Information List Table Janssen Products Tuberculosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Janssen Products Tuberculosis Drugs Sales Growth Rate (2012-2017) Figure Janssen Products Tuberculosis Drugs Sales USA Market Share (%) (2012-2017) Figure Janssen Products Tuberculosis Drugs Revenue USA Market Share (%) (2012-2017) Table First-line Anti-TB Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Second-line Anti-TB Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Janssen Products Tuberculosis Drugs Volume in and Its Application Share Table Janssen Products Tuberculosis Drugs Volume in and Its Application Share Table Janssen Products Tuberculosis Drugs Volume in and Its Application Share Table Otsuka Basic Information List Table Otsuka Tuberculosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Otsuka Tuberculosis Drugs Sales Growth Rate (2012-2017) Figure Otsuka Tuberculosis Drugs Sales USA Market Share (%) (2012-2017) Figure Otsuka Tuberculosis Drugs Revenue USA Market Share (%) (2012-2017) Table First-line Anti-TB Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Second-line Anti-TB Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Otsuka Tuberculosis Drugs Volume in and Its Application Share Table Otsuka Tuberculosis Drugs Volume in and Its Application Share Table Otsuka Tuberculosis Drugs Volume in and Its Application Share Table AstraZeneca Basic Information List Table AstraZeneca Tuberculosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure AstraZeneca Tuberculosis Drugs Sales Growth Rate (2012-2017) Figure AstraZeneca Tuberculosis Drugs Sales USA Market Share (%) (2012-2017) Figure AstraZeneca Tuberculosis Drugs Revenue USA Market Share (%) (2012-2017) Table First-line Anti-TB Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Second-line Anti-TB Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table AstraZeneca Tuberculosis Drugs Volume in and Its Application Share Table AstraZeneca Tuberculosis Drugs Volume in and Its Application Share Table AstraZeneca Tuberculosis Drugs Volume in and Its Application Share Table Lupin Pharmaceuticals Basic Information List Table Lupin Pharmaceuticals Tuberculosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Lupin Pharmaceuticals Tuberculosis Drugs Sales Growth Rate (2012-2017) Figure Lupin Pharmaceuticals Tuberculosis Drugs Sales USA Market Share (%) (2012-2017) Figure Lupin Pharmaceuticals Tuberculosis Drugs Revenue USA Market Share (%) (2012-2017) Table First-line Anti-TB Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Second-line Anti-TB Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Lupin Pharmaceuticals Tuberculosis Drugs Volume in and Its Application Share Table Lupin Pharmaceuticals Tuberculosis Drugs Volume in and Its Application Share Table Lupin Pharmaceuticals Tuberculosis Drugs Volume in and Its Application Share Table Akorn Basic Information List Table Akorn Tuberculosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Akorn Tuberculosis Drugs Sales Growth Rate (2012-2017) Figure Akorn Tuberculosis Drugs Sales USA Market Share (%) (2012-2017) Figure Akorn Tuberculosis Drugs Revenue USA Market Share (%) (2012-2017) Table First-line Anti-TB Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Second-line Anti-TB Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Akorn Tuberculosis Drugs Volume in and Its Application Share Table Akorn Tuberculosis Drugs Volume in and Its Application Share Table Akorn Tuberculosis Drugs Volume in and Its Application Share Table STI Pharma Basic Information List Table STI Pharma Tuberculosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure STI Pharma Tuberculosis Drugs Sales Growth Rate (2012-2017) Figure STI Pharma Tuberculosis Drugs Sales USA Market Share (%) (2012-2017) Figure STI Pharma Tuberculosis Drugs Revenue USA Market Share (%) (2012-2017) Table First-line Anti-TB Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Second-line Anti-TB Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table STI Pharma Tuberculosis Drugs Volume in and Its Application Share Table STI Pharma Tuberculosis Drugs Volume in and Its Application Share Table STI Pharma Tuberculosis Drugs Volume in and Its Application Share Table Sandoz Basic Information List Table Sandoz Tuberculosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Sandoz Tuberculosis Drugs Sales Growth Rate (2012-2017) Figure Sandoz Tuberculosis Drugs Sales USA Market Share (%) (2012-2017) Figure Sandoz Tuberculosis Drugs Revenue USA Market Share (%) (2012-2017) Table First-line Anti-TB Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Second-line Anti-TB Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Sandoz Tuberculosis Drugs Volume in and Its Application Share Table Sandoz Tuberculosis Drugs Volume in and Its Application Share Table Sandoz Tuberculosis Drugs Volume in and Its Application Share Table Company Labatec Pharma SA Basic Information List Table Company Labatec Pharma SA Tuberculosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Company Labatec Pharma SA Tuberculosis Drugs Sales Growth Rate (2012-2017) Figure Company Labatec Pharma SA Tuberculosis Drugs Sales USA Market Share (%) (2012-2017) Figure Company Labatec Pharma SA Tuberculosis Drugs Revenue USA Market Share (%) (2012-2017) Table First-line Anti-TB Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Second-line Anti-TB Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Company Labatec Pharma SA Tuberculosis Drugs Volume in and Its Application Share Table Company Labatec Pharma SA Tuberculosis Drugs Volume in and Its Application Share Table Company Labatec Pharma SA Tuberculosis Drugs Volume in and Its Application Share Table USA Tuberculosis Drugs Sales (K Units) by Players/Manufacturers (2012-2017) Table USA Tuberculosis Drugs Sales Share (%) by Players/Manufacturers (2012-2017) Figure 2016 USA Tuberculosis Drugs Sales Market Share (%) by Players/Manufacturers Figure 2017 USA Tuberculosis Drugs Sales Share by Players/Manufacturers Table USA Tuberculosis Drugs Revenue (Million USD) by Players/Manufacturers (2012-2017) Table USA Tuberculosis Drugs Revenue Market Share (%) Players/Manufacturers (2012-2017) Figure 2016 USA Tuberculosis Drugs Revenue Market Share (%) Players Figure 2017 USA Tuberculosis Drugs Revenue Market Share (%) Players Table USA Tuberculosis Drugs Sales (K Units) and Market Share (%) by Type (2012-2017) Table USA Tuberculosis Drugs Sales Share by Type (2012-2017) Figure Sales Market Share of Tuberculosis Drugs by Type (2012-2017) Figure USA Tuberculosis Drugs Sales Growth Rate (%) by Type (2012-2017) Table USA Tuberculosis Drugs Revenue (Million USD) and Market Share (%) Type (2012-2017) Table USA Tuberculosis Drugs Revenue Market Share (%) Type (2012-2017) Figure Revenue Market Share of Tuberculosis Drugs by Type (2012-2017) Figure USA Tuberculosis Drugs Revenue Growth Rate by Type (2012-2017) Table USA Tuberculosis Drugs Sales (K Units) and Market Share by Regions (2012-2017) Table USA Tuberculosis Drugs Sales Share by Regions (2012-2017) Figure Sales Market Share of Tuberculosis Drugs by Regions (2012-2017) Figure USA Tuberculosis Drugs Sales Market Share by Regions in 2017 Table USA Tuberculosis Drugs Revenue (Million USD) and Market Share by Regions (2012-2017) Table USA Tuberculosis Drugs Revenue Share (%) by Regions (2012-2017) Figure Revenue Market Share of Tuberculosis Drugs by Regions (2012-2017) Figure USA Tuberculosis Drugs Revenue Market Share by Regions in 2017 Table USA Tuberculosis Drugs Sales (K Units) and Market Share by Application (2012-2017) Table USA Tuberculosis Drugs Sales Share (%) by Application (2012-2017) Figure USA Tuberculosis Drugs Sales Market Share by Application (2012-2017) Figure USA Tuberculosis Drugs Sales Market Share by Application (2012-2017) Figure Northeast Tuberculosis Drugs Sales (K Units) and Growth Rate (%) (2012-2017) Figure Northeast Tuberculosis Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Northeast Tuberculosis Drugs Sales Price (USD/Unit) Trend (2012-2017) Table Northeast Tuberculosis Drugs Sales (K Units) by Type (2012-2017) Table Northeast Tuberculosis Drugs Sales (K Units) Market Share by Type (2012-2017) Figure Northeast Tuberculosis Drugs Sales (K Units) Market Share by Type in 2017 Table Northeast Tuberculosis Drugs Sales (K Units) by Applications (2012-2017) Table Northeast Tuberculosis Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure Northeast Tuberculosis Drugs Sales (K Units) Market Share by Applications in 2017 Figure Midwest Tuberculosis Drugs Sales (K Units) and Growth Rate (2012-2017) Figure Midwest Tuberculosis Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Midwest Tuberculosis Drugs Sales Price (USD/Unit) Trend (2012-2017) Table Midwest Tuberculosis Drugs Sales (K Units) by Type (2012-2017) Table Midwest Tuberculosis Drugs Sales (K Units) Market Share by Type (2012-2017) Figure Midwest Tuberculosis Drugs Sales (K Units) Market Share by Type in 2017 Table Midwest Tuberculosis Drugs Sales (K Units) by Applications (2012-2017) Table Midwest Tuberculosis Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure Midwest Tuberculosis Drugs Sales (K Units) Market Share by Applications in 2017 Figure South Tuberculosis Drugs Sales (K Units) and Growth Rate (2012-2017) Figure South Tuberculosis Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure South Tuberculosis Drugs Sales Price (USD/Unit) Trend (2012-2017) Table South Tuberculosis Drugs Sales (K Units) by Type (2012-2017) Table South Tuberculosis Drugs Sales (K Units) Market Share by Type (2012-2017) Figure South Tuberculosis Drugs Sales (K Units) Market Share by Type in 2017 Table South Tuberculosis Drugs Sales (K Units) by Applications (2012-2017) Table South Tuberculosis Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure South Tuberculosis Drugs Sales (K Units) Market Share by Applications in 2017 Figure West Tuberculosis Drugs Sales (K Units) and Growth Rate (2012-2017) Figure West Tuberculosis Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure West Tuberculosis Drugs Sales Price (USD/Unit) Trend (2012-2017) Table West Tuberculosis Drugs Sales (K Units) by Type (2012-2017) Table West Tuberculosis Drugs Sales (K Units) Market Share by Type (2012-2017) Figure West Tuberculosis Drugs Sales (K Units) Market Share by Type in 2017 Table West Tuberculosis Drugs Sales (K Units) by Applications (2012-2017) Table West Tuberculosis Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure West Tuberculosis Drugs Sales (K Units) Market Share by Applications in 2017 Table Distributors/Traders List Figure USA Tuberculosis Drugs Sales (K Units) and Growth Rate Forecast (2018-2023) Figure USA Tuberculosis Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure USA Tuberculosis Drugs Price and Trend Forecast (2018-2023) Table USA Tuberculosis Drugs Sales (K Units) Forecast by Regions (2018-2023) Figure USA Tuberculosis Drugs Sales (K Units) Market Share Forecast by Regions (2018-2023) Figure USA Tuberculosis Drugs Sales (K Units) Market Share Forecast by Regions in 2023 Table USA Tuberculosis Drugs Revenue (Million USD) Forecast by Regions (2018-2023) Figure USA Tuberculosis Drugs Revenue Market Share Forecast by Regions (2018-2023) Figure USA Tuberculosis Drugs Revenue Market Share Forecast by Regions in 2023 Figure Northeast Tuberculosis Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Northeast Tuberculosis Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure South Tuberculosis Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure South Tuberculosis Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Midwest Tuberculosis Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Midwest Tuberculosis Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure West Tuberculosis Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure West Tuberculosis Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Table USA Tuberculosis Drugs Sales (K Units) Forecast by Type (2018-2023) Figure USA Tuberculosis Drugs Sales Market Share Forecast by Type (2018-2023) Table USA Tuberculosis Drugs Revenue (Million USD) Forecast by Type (2018-2023) Figure USA Tuberculosis Drugs Revenue Market Share Forecast by Type (2018-2023) Table USA Tuberculosis Drugs Price (USD/Unit) Forecast by Type (2018-2023) Table USA Tuberculosis Drugs Sales (K Units) Forecast by Application (2018-2023) Figure USA Tuberculosis Drugs Sales Market Share Forecast by Application (2018-2023) Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Sanofi Pfizer Janssen Products Otsuka AstraZeneca Lupin Pharmaceuticals Akorn STI Pharma Sandoz Labatec Pharma SA Archivel Farma BioMerieux Cepheid Epistem